| | | | | | | | | Sponsored | | Support earlier, more connected cardiometabolic insight with Siemens Healthineers. Includes the first and only prognostic high-sensitivity troponin I assay available in the U.S. and the first and only blood test authorized for use as a prognostic marker in patients with advanced fibrosis due to MASH. Enable a more complete testing approach without added complexity. |
|
|
| | |
| |
| | |
|
|
| | | | | | Findings from a collaborative study between Adelaide University and NT Health show that the meningococcal B (MenB) vaccine could lower the risk of gonorrhea in people aged 14-22. |
|
|
| | This analysis examines publicly available essential functions across U.S. phlebotomy programs, identifying five core domains that support student readiness and patient safety while emphasizing the need for standardized, inclusive language aligned with ADA principles. |
|
|
|
| |
| | |
|
|
| | | | | | Sponsored | | Mass spectrometry is revolutionizing healthcare by providing more precise and reliable diagnostics. This innovative technology accurately measures complex biological samples, offering valuable insights to healthcare professionals. By improving diagnostic test accuracy, mass spectrometry supports better-informed decisions and more tailored, effective patient care. |
|
|
| | |
| |
| | |
|
|
| | | | | | Beckman Coulter Diagnostics, a Danaher company, recently announced the U.S. launch of the DxU 1800 System, a fully automated urinalysis solution that combines a new chemistry analyzer and consumables with proven microscopy technology. |
|
|
|
| |
| | |
|
|
| | | | | | Congress has reintroduced the Timely Access to Coverage Decisions Act, legislation aimed at increasing transparency, accountability, and consistency in the Medicare LCD process. Learn what the proposed reforms could mean for laboratories, diagnostic innovation, and Medicare coverage decisions. |
|
|
|
| |
| | |
|
|
| | | | | | NIPRO CORPORATION has been granted 510(k) clearance for the ELISIO-HX dialyzer by the U.S. Food and Drug Administration (FDA), enabling the introduction of hemodialysis powered by super high-flux membrane (HDs) in the United States. |
|
|
|
| |
| | |
|
|
| | |
|
| | |
|